The Latest
-
Chip Somodevilla via Getty Images
AdvaMed calls for series of trade actions in response to Section 232 probe
In comments submitted to the Trump administration on its medical equipment investigation, the industry group recommended a tariff-free trading bloc with trusted countries among its proposals.
-
Courtesy of Dexcom
Dexcom faces proposed class action suit over G7 CGM problems
The parent of a child who wore the device to manage diabetes described failed alerts and inaccurate readings in a complaint.
-
Getty Images
HHS says it can still fire workers despite judge’s order pausing shutdown layoffs
The 982 HHS employees who received reduction-in-force notices are not represented by the unions that are plaintiffs in the case, the department’s head of personnel argued in a court filing.
-
Courtesy of Oura
Ōura to pursue FDA clearance of blood pressure feature for smart ring
The company has received approval to validate and define the feature in a study that is scheduled to start this year.
-
Courtesy of Boston Scientific
Boston Scientific to buy Nalu Medical for $533M
Nalu’s implantable neurostimulation system delivers electrical impulses to treat chronic pain originating from the peripheral nerves.
-
Mario Tama via Getty Images
What J&J’s ortho spinoff means for the industry
Analysts expect that DePuy Synthes could become a stronger competitor as a standalone company.
-
Courtesy of Ōura
Ōura raises $900M to develop new health features
The investment values the smart-ring maker at $11 billion.
-
Permission granted by Histosonics
HistoSonics raises $250M to expand use of noninvasive cancer therapy
The company raised money from Bezos Expeditions, Thiel Bio and other investors to fund the commercial and clinical expansion of its technology.
-
Courtesy of BD
BD CFO Chris DelOrefice leaving for new job
Along with DelOrefice’s departure, BD reported preliminary fiscal fourth-quarter revenue that analysts said was below Wall Street consensus expectations.
-
Elise Reuter/MedTech Dive, data from MedTech Dive
5 AI takeaways from AdvaMed’s conference
Medical device firms discussed privacy, regulations and prioritizing projects as AI becomes more prevalent in the industry.
-
Courtesy of Johnson & Johnson
J&J plans to spin out orthopedics business
CEO Joaquin Duato said the spinout will help the healthcare giant focus on medtech areas with higher growth and margins, such as cardiovascular and robotics.
-
Alamy
Abbott CEO: ‘We’re right on time’ to the PFA party
As competitors have launched their first pulsed field ablation devices in the U.S., Abbott CEO Robert Ford told investors that the company is not just playing defense.
-
Bill Pugliano via Getty Images
To move or not to move? Manufacturers hesitant to nearshore before USMCA review
While some companies are using regional supply chains or leaning on tariff exemptions by maximizing compliance, others are frozen in place.
-
Getty Images
Stereotaxis teams with CardioFocus to develop robotic PFA system
Stereotaxis CEO David Fischel said the precision, stability and safety profile of robotics are a good fit for pulsed field ablation.
-
Courtesy of Abiomed
Cybersecurity triggers another recall of J&J’s Impella heart pump controller
While no patients have been harmed, the FDA categorized the action as a Class I recall because of the potential for serious injury or death.
-
Getty Images
Trump administration moves to fire HHS employees amid shutdown
Upwards of 1,000 HHS employees were affected. However, the department has rolled back some of the layoffs at the CDC, where the brunt of the terminations were concentrated.
Updated Oct. 14, 2025 -
Courtesy of Intuitive Surgical
Intuitive expands AI in Ion; Horizon performs first robotic cataract surgery
The FDA cleared AI and imaging updates for Intuitive’s lung biopsy robot. Elsewhere, Horizon completed the first cataract surgery with its robotic system, and MMI began a neurosurgical study.
